Paper3079883
Use and misuse of the term "cost effective" in medicine.
Doubilet P and 2 others. N Engl J Med, 1986. Cited by 347 papers, by iCite.
Cite this record
ConductScience Library. Use and misuse of the term "cost effective" in medicine. Papers, record 3079883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3079883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cost-Benefit Analysis | Major topic |
| Terminology as Topic | Major topic |
| Cost Control | |
| Efficiency | |
| Outcome and Process Assessment, Health Care |
Source PubMed
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 347 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40880170 | Developing and Validating an Inclusive and Cost-Effective Prediction Algorithm for Survival and Death Among People Living With HIV in Sub-Saharan Africa: Protocol for a Meta-Analysis and Case-Control and Cost-Effectiveness Study. | JMIR Res Protoc | 2025 | https://conductscience.org/library/papers/40880170 | PubMed |
| 39367462 | Insights and networks: methodological assessment and scientometric analysis of economic evaluations in dentistry. | BMC Health Serv Res | 2024 | https://conductscience.org/library/papers/39367462 | PubMed |
| 31523742 | Introducing a reserve waiting list initiative for elective general surgery at a District General Hospital. | BMJ Open Qual | 2019 | https://conductscience.org/library/papers/31523742 | PubMed |
| 26379829 | Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26379829 | PubMed |
| 26258804 | Cost-effectiveness of physical activity among women with menopause symptoms: findings from a randomised controlled trial. | PLoS One | 2015 | https://conductscience.org/library/papers/26258804 | PubMed |
| 26205890 | Cost-effectiveness of vitamin D supplementation and exercise in preventing injurious falls among older home-dwelling women: findings from an RCT. | Osteoporos Int | 2016 | https://conductscience.org/library/papers/26205890 | PubMed |
| 25446479 | Laparoscopic anterior versus posterior fundoplication for gastro-esophageal reflux disease: a meta-analysis and systematic review. | World J Surg | 2015 | https://conductscience.org/library/papers/25446479 | PubMed |
| 24292986 | XRCC1 R399Q polymorphism and risk of normal tissue injury after radiotherapy in breast cancer patients. | Tumour Biol | 2014 | https://conductscience.org/library/papers/24292986 | PubMed |
| 23990458 | Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis. | Tumour Biol | 2013 | https://conductscience.org/library/papers/23990458 | PubMed |
| 23767423 | Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance. | J Cardiovasc Magn Reson | 2013 | https://conductscience.org/library/papers/23767423 | PubMed |
| 23765759 | Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk. | Tumour Biol | 2013 | https://conductscience.org/library/papers/23765759 | PubMed |
| 22438008 | Clinical trials in orthopaedics research. Part III. Overcoming operational challenges in the design and conduct of randomized clinical trials in orthopaedic surgery. | J Bone Joint Surg Am | 2012 | https://conductscience.org/library/papers/22438008 | PubMed |
| 17958883 | Cost-effectiveness analysis of guidelines for antihypertensive care in Finland. | BMC Health Serv Res | 2007 | https://conductscience.org/library/papers/17958883 | PubMed |
| 17872931 | New methods of analysing cost effectiveness. | BMJ | 2007 | https://conductscience.org/library/papers/17872931 | PubMed |
| 17197978 | Methodologic quality of cost-effectiveness analyses of surgical procedures. | Ann Surg | 2007 | https://conductscience.org/library/papers/17197978 | PubMed |
| 17067196 | Information created to evade reality (ICER): things we should not look to for answers. | Pharmacoeconomics | 2006 | https://conductscience.org/library/papers/17067196 | PubMed |
| 16492068 | Estimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertension. | Drugs Aging | 2006 | https://conductscience.org/library/papers/16492068 | PubMed |
| 14974877 | The NICE reference case requirement: more pain for what, if any, gain? | Pharmacoeconomics | 2004 | https://conductscience.org/library/papers/14974877 | PubMed |
| 11096723 | Primary Central Nervous System Tumors in Adults. | Curr Treat Options Neurol | 1999 | https://conductscience.org/library/papers/11096723 | PubMed |
| 10947301 | Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome. | Pharmacoeconomics | 2000 | https://conductscience.org/library/papers/10947301 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3079883
GET https://conductscience.org/api/papers/v1/3079883/cited_by?page=2